OIG, the Office of the Inspector General of the U.S. Department of Health and Human Services published Compliance Program Guidance for Pharmaceutical Manufacturers on April 28, 2003. The present guidance deals specifically with the healthcare industry. Goal of the guidance is to recommend pharmaceutical manufacturer to be compliant with existing health care laws and regulations which includes False Claims Act, Medicaid Drug Rebate Act etc.
